Teva
Mega deal: Teva acquires Emalex for approximately $900 million
The Israeli pharmaceutical giant is accelerating its growth strategy and adding to its portfolio a groundbreaking treatment for Tourette syndrome in children.
IATI CEOs Forum meets in Kiryat Gat to discuss multinational industry resilience
Teva honored for gender equality as women reach 43% of senior management in Israel
Teva collaborates on skin disease treatment, releases targets
Grapevine: Screaming sumo
Movers and shakers in Israeli society.
Teva, Allergan reach $161.5 million opioid settlement with West Virginia
The agreement is the largest state-negotiated settlement in West Virginia history and consists of $134 million in cash plus the contribution of drugs used to treat opioid overdoses.
State sues Teva over Copaxone drug royalties
Two doctors sued Teva for failing to acknowledge their contributions and demanded to be compensated with royalties stemming from the new version of copaxone.
Ukrainian refugees offered free medical services in Israel
Many of them are not Jewish and are therefore ineligible for access to universal healthcare in Israel.
Rhode Island takes Teva to trial in multibillion-dollar opioid case
The multibillion-dollar trial will determine whether the Israeli company contributed to an opioid crisis that has caused more than 500,000 deaths over the past two decades.
Teva, Texas strike opioid settlement worth $225 million
Teva Pharmaceutical Industries Ltd was facing claims that they fueled an opioid epidemic in Texas by improperly marketing addictive pain medications.
Drugmaker Teva fueled opioid addiction in New York, jury finds
New York and Nassau and Suffolk counties had accused the Israel-based drugmaker of engaging in misleading marketing practices that fueled opioid addiction in the state.
California judge rules for Israeli Teva in major opioid lawsuit
The lawsuit was originally filed in April, when several California counties accused drugmakers of fueling America's opioid crisis.
Israeli team says AI platform can predict which drugs are safe, effective
Quris, an artificial intelligence (AI) company operating in the pharmaceutical space, launched this week and announced a $9 million in seed funding.
Pfizer, AstraZeneca help launch 'computational science' lab in Israel
A partnership between six leading tech and pharma companies wants to create and adopt new AI technologies that could transform the process of drug discovery and development.
